Potential impact of AUSFTA on Australia's blood supply

Alison Turner and Albert Farrugia
Med J Aust 2007; 186 (8): . || doi: 10.5694/j.1326-5377.2007.tb00984.x
Published online: 16 April 2007

To the Editor: Bambrick et al1 suggest that the importation of overseas plasma products or the processing of Australian plasma overseas may pose a threat to the safety and security of Australia’s supply of plasma products. The National Blood Authority (NBA) and the Therapeutic Goods Administration (TGA) would like to respond to these issues to ensure that clinicians have confidence in the safety of products currently available in Australia and a better understanding of current blood processing and supply arrangements.

  • Alison Turner1
  • Albert Farrugia2

  • 1 Office of Devices, Blood and Tissues, Therapeutic Goods Administration, Canberra, ACT.
  • 2 National Blood Authority, Canberra, ACT.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.